• Return to Headlines

SmarTrend Watching for Potential Rebound in Shares of Myriad Genetics After 41.19% Loss

By David Diaz

Myriad Genetics (NASDAQ:MYGN) traded in a range yesterday that spanned from a low of $25.53 to a high of $29.17. Yesterday, the shares fell 41.2%, which took the trading range below the 3-day low of $41.41 on volume of 7.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

In the past 52 weeks, Myriad Genetics share prices have been bracketed by a low of $22.07 and a high of $50.44 and are now at $25.58, 16% above that low price. The 200-day and 50-day moving averages have moved 0.10% higher and 4.37% higher over the past week, respectively.

SmarTrend recommended that subscribers consider buying shares of Myriad Genetics on July 1st, 2019 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $27.87. Since that recommendation, shares of Myriad Genetics have risen 59.8%. We continue to monitor MYGN for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: rebounders myriad genetics

Ticker(s): MYGN